NowRx Stock

nowrx.comHealthcare / Healthcare providers & servicesFounded: 2015Funding to Date: $114.11MM

NowRx, founded in 2015, is a technology-enabled pharmacy that uses proprietary pharmacy software, robotics, AI, and last-mile logistics to provide free same-day delivery of prescription medications. NowRx is a retail pharmacy just like any other, except instead of customers coming into the store to pick up their medications, they are delivered in hours - free of charge.

Register To Buy and Sell Shares

For more details on financing and valuation for NowRx, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access NowRx’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like NowRx.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

NowRx investors also invested in these private companies

Decathlon Capital Partners
Visary Capital
Gershon Capital
Logical Venture Partners
Envlp Ventures


Management Team

Cary Breese
Co-Founder & Chief Executive Officer
Sumeet Sheokand
Co-Founder & Chief Technology Officer
Mark Marlow
Chief Financial Officer

Frequently Asked Questions About NowRx’s Stock

Can you buy NowRx’s stock?
NowRx is not publicly traded on NYSE or NASDAQ in the U.S. To buy NowRx’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell NowRx’s stock?
Yes, you can sell stock of a private company like NowRx. Forge can help you sell your NowRx stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is NowRx’s stock price?
NowRx is a privately held company and therefore does not have a public stock price. However, you may access NowRx’s private market stock price with Forge Data.
What is NowRx’s stock ticker symbol?
NowRx does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

NowRx is bringing prescription delivery to your front door | Engadget
This growing company has turned to equity crowdfunding to expand their tech-powered pharmacy concept..
Prescription startup NowRx is crowdfunding its latest $73 million funding round. Here's why CEO Cary Breese decided to avoid VCs.
NowRx's CEO sees several benefits to crowdfunding, like not getting pressure from VCs to scale too quickly and gaining a marketing advantage.
NowRX Returns to SeedInvest For Series C Funding in Reg A+ Offering
NowRX, has returned to SeedInvest for its Series C funding round. According to the offering page, NowRX is raising capital at a pre-money valuation of $275 million. The size of the round is indicative of the ability for more mature firms to raise capital online. This is the 4th time NowRX has utilized the SeedInvest platform with its Seris B round raising around $20 million – SeedInvest’s largest securities offering to date.
Updated on: May 18, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.